Compare Biogen Inc (BIIB) vs Campbell Soup Co. (CPB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Campbell Soup Co. — how do they compare? Biogen Inc trades at $191.4 (market cap $30.86B), while Campbell Soup Co. trades at $22.22 (market cap $6.60B). The key difference: Biogen Inc is far larger — about 4.7× Campbell Soup Co.'s market cap, and Campbell Soup Co. pays a 7.05% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | CPB | |
|---|---|---|
Market Cap | $30.86B | $6.60B |
Sector | Health | Consumer Staples |
52-Week High | $216.63 | $34.03 |
52-Week Low | $122.68 | $20.00 |
Enterprise Value | $33.14B | $13.21B |
Dividend Yield | — | 7.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Campbell Soup Co.
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →
